Refaat R Kamel
Overview
Explore the profile of Refaat R Kamel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ezzat W, Amr K, Elhosary Y, Hegazy A, Fahim H, Eltaweel N, et al.
Gene
. 2019 Mar;
702:153-157.
PMID: 30922710
Irregular methylation, including DNA hypomethylation and/or promoter gene CpG hypermethylation, is involved in the pathogenesis of several solid tumors, including liver cancer. miRNAs are small, endogenous, noncoding RNAs that serve...
2.
Afify M, Kamel R, Elhosary Y, Hegazy A, Fahim H, Ezzat W
J Genet Eng Biotechnol
. 2019 Jan;
13(2):157-163.
PMID: 30647579
Background: Hepatocellular carcinoma (HCC) is regarded as one of the most common malignancies and among the leading causes of cancer death in the whole world. Apoptosis is a fundamental process...
3.
Ezzat W, Amr K, Raouf H, Elhosary Y, Hegazy A, Fahim H, et al.
Arch Med Res
. 2016 Oct;
47(5):349-355.
PMID: 27751368
Background And Aims: Activation of telomerase reverse transcriptase (hTERT) has a role in liver carcinogenesis where telomerase is normally suppressed in most human somatic tissues after birth. In the current...
4.
Kamel R, Amr K, Afify M, Elhosary Y, Hegazy A, Fahim H, et al.
Open Access Maced J Med Sci
. 2016 Jun;
4(1):31-7.
PMID: 27275325
Aim: To determine the relation between serum microRNAs and apoptotic markers as regards development of HCC to understand the underlying mechanism of HCV related hepatocarcinogenesis. Patients And Methods: A total...
5.
Amr K, Ezzat W, Elhosary Y, Hegazy A, Fahim H, Kamel R
Gene
. 2015 Aug;
575(1):66-70.
PMID: 26302751
Background: Hepatocellular carcinoma (HCC) is regarded as one of the most common malignancies and among the leading causes of cancer death among the whole world. The most urgent needs are...
6.
Kamal S, Fouly A, Kamel R, Hockenjos B, Al Tawil A, Khalifa K, et al.
Gastroenterology
. 2006 Mar;
130(3):632-8.
PMID: 16530503
Background & Aims: Pegylated interferon therapy has not been adequately evaluated in acute hepatitis C virus (HCV) infection. This randomized trial assessed the efficacy, safety, and timing of pegylated interferon...